Cogstate Limited (CGS.AX)

1,2700 -0,0300 (-2,31%) Ab 02:06PM AEST. Markt geöffnet.

Cogstate Limited

367 Collins Street
Level 32
Melbourne, VIC 3000
Australia
61 3 9664 1300
https://www.cogstate.com

Sektor(en): Healthcare
Branche: Health Information Services
Vollzeitmitarbeiter: 158

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Bradley John O'Connor B.Bus, C.A., CA	CEO, MD & Executive Director	910,31k	N/A	N/A
Prof. Paul Maruff BBSc (Hons), Ph.D.	Founder & Chief Innovation Officer	N/A	N/A	N/A
Mr. Darren Watson	Chief Financial Officer	553,15k	N/A	N/A
Mr. Benjamin Bloomfield	Chief Technology Officer	466,43k	N/A	N/A
Dr. Chris Edgar Ph.D.	Chief Science Officer	522,6k	N/A	N/A
Mr. Kenneth Billard	Chief Commercial Officer	647,88k	N/A	N/A
Ms. Rachel Colite	Executive VP of Clinical Trials	451,72k	N/A	N/A
Ms. Kristi Geddes	General Counsel, Joint Company Secretary & Director	N/A	N/A	N/A
Mr. David James Franks BEc, C.A., F Fin, J.P.	Joint Company Secretary	N/A	N/A	1970

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is also involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company also provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2023, it had participated in approximately 1,800 academic research studies and 530 industry sponsored clinical trials. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

Corporate Governance

Cogstate Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.